![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
1. Doral
2. Quiedorm
3. Sch 16134
4. Sch-16134
1. Doral
2. Prosedar
3. Quazium
4. Dormalin
5. Oniria
6. Selepam
7. 36735-22-5
8. Sch 16134
9. Quazepamum [inn-latin]
10. Sch-16134
11. Quazepam Civ
12. 7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3h-1,4-benzodiazepine-2-thione
13. 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2h-1,4-benzodiazepine-2-thione
14. Nsc-309702
15. Chebi:8694
16. Jf8v0828zi
17. 2h-1,4-benzodiazepine-2-thione, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-
18. Quazepamum
19. Quazapam
20. Cetrane
21. Doral [sedative]
22. 7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1h-1,4-benzodiazepine-2-thione
23. Doral (tn)
24. Einecs 253-179-4
25. Nsc 309702
26. Quazepam (jan/usp/inn)
27. Sch-161
28. Brn 0901084
29. Unii-jf8v0828zi
30. Dea No. 2881
31. Quazepam [usan:usp:inn:ban]
32. Quazepam [usan]
33. Quazepam [inn]
34. Quazepam [jan]
35. Quazepam [mi]
36. Quazepam [vandf]
37. Quazepam Civ(200 Mg)
38. Quazepam [mart.]
39. Quazepam [who-dd]
40. Schembl29504
41. 5-24-04-00356 (beilstein Handbook Reference)
42. Quazepam [orange Book]
43. Quazepam Civ [usp-rs]
44. Gtpl7288
45. Chembl1200472
46. Quazepam [usp Monograph]
47. Dtxsid60190193
48. Zinc538266
49. Nsc309702
50. Db01589
51. C07336
52. D00457
53. 735q225
54. Q3927403
55. 2h-1, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-
56. 7-chloro-5-(o-fluorophenyl)-1,2,2-trifluoroethyl)-2h-1,4-benzodiazepine-2-thione
Molecular Weight | 386.8 g/mol |
---|---|
Molecular Formula | C17H11ClF4N2S |
XLogP3 | 4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 2 |
Exact Mass | 386.0267599 g/mol |
Monoisotopic Mass | 386.0267599 g/mol |
Topological Polar Surface Area | 47.7 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 539 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Doral |
PubMed Health | Quazepam (By mouth) |
Drug Classes | Hypnotic |
Drug Label | DORAL contains quazepam, a trifluoroethyl benzodiazepine hypnotic agent, having the chemical name 7-chloro-5- (o-fluoro-phenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione and the following structural formula:Quazepam has the... |
Active Ingredient | Quazepam |
Dosage Form | Tablet |
Route | Oral |
Strength | 15mg |
Market Status | Prescription |
Company | Sciecure Pharma |
2 of 2 | |
---|---|
Drug Name | Doral |
PubMed Health | Quazepam (By mouth) |
Drug Classes | Hypnotic |
Drug Label | DORAL contains quazepam, a trifluoroethyl benzodiazepine hypnotic agent, having the chemical name 7-chloro-5- (o-fluoro-phenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione and the following structural formula:Quazepam has the... |
Active Ingredient | Quazepam |
Dosage Form | Tablet |
Route | Oral |
Strength | 15mg |
Market Status | Prescription |
Company | Sciecure Pharma |
Used to treat insomnia.
Quazepam is a benzodiazepine derivative. The main pharmacological action of quazepam is the enhancement of the neurotransmitter GABA at the GABAA receptor.
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
N - Nervous system
N05 - Psycholeptics
N05C - Hypnotics and sedatives
N05CD - Benzodiazepine derivatives
N05CD10 - Quazepam
Absorption
Bioavailability is 29-35% following oral administration.
Hepatic.
Quazepam has known human metabolites that include 2-oxoquazepam.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
39 hours